← Back to Clinical Trials
Recruiting NCT07764419

NCT07764419 Desensitization-Based Structured Intervention Program for Individuals With Stuttering

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07764419
Status Recruiting
Phase
Sponsor DİLARA BASER
Condition Stuttering
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2026-07-20
Primary Completion 2027-01-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Structured Desensitization-Based Job Interview Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 36 participants in total. It began in 2026-07-20 with a primary completion date of 2027-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Stuttering is a common fluency disorder characterized by involuntary interruptions in speech flow, such as repetitions, prolongations, and blocks. It affects approximately 1% of the world's population and typically emerges in the early stages of language development, particularly in preschool. The exact cause of stuttering is still unknown, but it is believed to involve various combinations of genetic, developmental, environmental, and neurophysiological factors (Yairi and Ambrose, 2013). Stuttering not only affects an individual's communication skills but can also significantly impact their psychological and emotional state. Individuals may experience persistent anxiety about being ridiculed or negatively evaluated by others during stuttering episodes, and the pressure to speak fluently in everyday situations can create significant stress and anxiety (Guitar, 2013). The ICF model, developed by the World Health Organization, suggests examining an individual's health status not only at the biological level but also in the context of activity, participation, and environmental factors (WHO, 2001). In particular, the ICF-based model proposed by J. Scott Yaruss and Robert W. Quesal for stuttering offers an important framework for explaining the impact of stuttering on an individual's quality of life. In this context, stuttering is characterized by limited participation in social and professional life in terms of the level of participation (Yaruss \& Quesal, 2004). Individuals with stuttering may experience a number of problems in their professional lives. Job interviews can be given as an example of these situations. Job interviews are an important starting point in the employment process. Job interviews are a situation that creates anxiety and causes avoidance behaviors for individuals with stuttering (Hohulin et al., 2010). Anxiety is defined as "unease, irrational fear, anxiety, worry, distress caused by an unknown danger, misfortune, fear or expectation originating from the unconscious" (Bakırcıoğlu, 2016: 893). When adult individuals with stuttering are faced with a socially threatening, anxiety-inducing environment, they show physical strain and their anxiety increases during stuttering (Bloodstein, 1995; Craig, 2003). The literature reports a positive correlation between threatening or challenging stimuli and the severity of stuttering. For example; Stuttering is observed to increase when speaking to an authority figure, a group, or impatient or critical listeners (Guitar, 2013). Conversely, the frequency of stuttering generally decreases in non-anxiety-inducing situations, such as speaking to a familiar person or someone who is not an authority figure (Craig, 2006). Furthermore, speakers with severe stuttering are more likely to be subjected to negative evaluations and labeling/stigmatization compared to speakers with less severe stuttering (Gabel, 2006). The fear of negative evaluation is defined by Leary (1983) as the individual being evaluated negatively and hostilely by others, or being stigmatized. Stigmatization, in turn, is described as a multidimensional phenomenon encompassing negative attitudes and behaviors towards individuals (Corrigan \& Watson, 2002). The literature includes various therapies for stuttering and the accompanying negative emotional states. One of these approaches is known as desensitization. Desensitization for stuttering is considered an important component of therapy for individuals who stutter. According to most research findings in foreign literature, individuals with stuttering perceive job interviews as a difficult area (Bricker-Katz, Lincoln, and Cumming, 2013; Klein and Hood, 2004; Rice and Kroll, 2006). Furthermore, while many studies focus on the working lives of individuals with stuttering, there are only a few studies specifically addressing job search processes and interviews. No studies addressing job interviews for individuals with stuttering have been found in the local literature. Due to this gap in the literature, our research aims to contribute to the literature and guide future studies in this area. Our study will develop a 10-week desensitization-based therapy program and aims to examine the effects of this structured program on stuttering frequency, fear of negative evaluation, internalized stigma, and anxiety experienced during interviews for individuals with stuttering.

Eligibility Criteria

Inclusion Criteria: * Aged 18-35, * Having had at least one job interview before, * Not actively receiving speech and language therapy support, * Having a stuttering frequency of 3% or higher Exclusion Criteria: * Lacking an ethical statement * Above-average results on Beck Depression and Beck Anxiety Inventories

Contact & Investigator

Central Contact

DİLARA BAŞER, MSc

✉ dilara.baser@fbu.edu.tr

📞 +905454546954

Frequently Asked Questions

Who can join the NCT07764419 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Stuttering. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07764419 currently recruiting?

Yes, NCT07764419 is actively recruiting participants. Contact the research team at dilara.baser@fbu.edu.tr for enrollment information.

Where is the NCT07764419 trial being conducted?

This trial is being conducted at Ataşehir, Turkey (Türkiye).

Who is sponsoring the NCT07764419 clinical trial?

NCT07764419 is sponsored by DİLARA BASER. The trial plans to enroll 36 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology